Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Opening the "Black Box" on Tezepelumab's Effect on Chronic Rhinosinusitis With Severe Asthma

NCT06740045 is registered in ClinicalTrials.gov with Dr. Andrew Thamboo, MD as lead sponsor.

NCT NCT06740045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06740045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Opening the "Black Box" on Tezepelumab's Effect on Chronic Rhinosinusitis With Severe Asthma
Lead sponsor
Dr. Andrew Thamboo, MD
Phase
Phase 3
Overall status
Not yet recruiting
Start date
January 31, 2025
Completion date
June 30, 2025
Enrollment
10 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, chronic rhinosinusitis with nasal polyps